Graybug Vision (GRAY) Competitors $1.71 -0.04 (-2.29%) As of 05/22/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock GRAY vs. SCNX, CLRB, CSCI, HOTH, BLRX, LSB, DWTX, TLPH, CYCN, and HCWBShould you be buying Graybug Vision stock or one of its competitors? The main competitors of Graybug Vision include Scienture (SCNX), Cellectar Biosciences (CLRB), COSCIENS Biopharma (CSCI), Hoth Therapeutics (HOTH), BioLineRx (BLRX), Lakeshore Biopharma (LSB), Dogwood Therapeutics (DWTX), Talphera (TLPH), Cyclerion Therapeutics (CYCN), and HCW Biologics (HCWB). These companies are all part of the "pharmaceutical preparations" industry. Graybug Vision vs. Scienture Cellectar Biosciences COSCIENS Biopharma Hoth Therapeutics BioLineRx Lakeshore Biopharma Dogwood Therapeutics Talphera Cyclerion Therapeutics HCW Biologics Graybug Vision (NASDAQ:GRAY) and Scienture (NASDAQ:SCNX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings, valuation and community ranking. Which has stronger valuation & earnings, GRAY or SCNX? Scienture has higher revenue and earnings than Graybug Vision. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGraybug VisionN/AN/A-$35.60M-$24.23-0.07Scienture$146.90K77.23-$17.84MN/AN/A Does the MarketBeat Community believe in GRAY or SCNX? Graybug Vision received 16 more outperform votes than Scienture when rated by MarketBeat users. CompanyUnderperformOutperformGraybug VisionOutperform Votes1650.00% Underperform Votes1650.00% ScientureN/AN/A Which has more volatility & risk, GRAY or SCNX? Graybug Vision has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, Scienture has a beta of 2.83, indicating that its share price is 183% more volatile than the S&P 500. Does the media refer more to GRAY or SCNX? In the previous week, Scienture had 2 more articles in the media than Graybug Vision. MarketBeat recorded 2 mentions for Scienture and 0 mentions for Graybug Vision. Scienture's average media sentiment score of 1.00 beat Graybug Vision's score of 0.00 indicating that Scienture is being referred to more favorably in the news media. Company Overall Sentiment Graybug Vision Neutral Scienture Positive Is GRAY or SCNX more profitable? Scienture's return on equity of -77.60% beat Graybug Vision's return on equity.Company Net Margins Return on Equity Return on Assets Graybug VisionN/A -77.61% -71.34% Scienture N/A -77.60%-62.29% Do institutionals and insiders have more ownership in GRAY or SCNX? 49.9% of Graybug Vision shares are held by institutional investors. Comparatively, 5.7% of Scienture shares are held by institutional investors. 7.9% of Graybug Vision shares are held by company insiders. Comparatively, 49.7% of Scienture shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryScienture beats Graybug Vision on 8 of the 10 factors compared between the two stocks. Get Graybug Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAY vs. The Competition Export to ExcelMetricGraybug VisionPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.69M$6.49B$5.33B$8.35BDividend YieldN/A2.64%5.20%4.10%P/E Ratio-0.998.5626.7419.65Price / SalesN/A258.46394.49119.78Price / CashN/A65.8538.3234.62Price / Book1.026.406.744.50Net Income-$35.60M$143.98M$3.23B$248.32M7 Day Performance-10.61%0.06%0.13%-0.96%1 Month Performance12.50%1.81%8.83%10.86%1 Year Performance-66.86%-0.92%18.45%9.08% Graybug Vision Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRAYGraybug VisionN/A$1.71-2.3%N/A-67.6%$2.69MN/A-0.9927High Trading VolumeSCNXScientureN/A$0.93-2.2%N/AN/A$12.17M$136,643.000.00N/ANews CoverageCLRBCellectar Biosciences2.3115 of 5 stars$0.26+1.8%$12.50+4,707.7%-92.1%$11.94MN/A-0.1510Analyst ForecastCSCICOSCIENS BiopharmaN/A$3.58-0.7%N/AN/A$11.25M$9.59M-0.3020Gap DownHOTHHoth Therapeutics2.7232 of 5 stars$0.85flat$4.00+370.6%-30.0%$11.23MN/A-0.644Analyst DowngradeBLRXBioLineRx1.6337 of 5 stars$3.37+3.1%$26.00+671.5%-84.7%$11.22M$28.94M-0.3840Upcoming EarningsGap DownLSBLakeshore Biopharma0.6982 of 5 stars$1.13+0.4%N/AN/A$10.53M$672.27M0.00773Positive NewsGap UpDWTXDogwood Therapeutics1.1809 of 5 stars$5.50-3.8%$10.00+82.0%N/A$10.50MN/A-0.845TLPHTalphera2.7403 of 5 stars$0.52+2.4%$5.00+857.9%-50.6%$10.46M$281,000.00-0.7419Gap DownCYCNCyclerion Therapeutics0.8126 of 5 stars$3.19+2.6%N/A+19.9%$10.29M$2.08M-2.7630HCWBHCW Biologics1.3484 of 5 stars$8.98+4.8%N/A-81.3%$10.22M$2.57M-9.1040Gap Down Related Companies and Tools Related Companies SCNX Competitors CLRB Competitors CSCI Competitors HOTH Competitors BLRX Competitors LSB Competitors DWTX Competitors TLPH Competitors CYCN Competitors HCWB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAY) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graybug Vision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Graybug Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GRAY Stock Free GRAY Stock Alerts